Text Message Reminders for Pediatric COVID-19 and Flu Vaccines
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if text message reminders help children receive their COVID-19 and flu vaccines on time. It will compare groups receiving different types of text reminders: some for both vaccines, some for just one, and some with no reminders. The trial targets children aged six months to 17 years who are due for both vaccines, receive care at a participating site, and have contact information for text messages in English or Spanish. As an unphased trial, this study provides an opportunity to contribute to improving vaccination rates through innovative communication methods.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that text message reminders are safe for pediatric vaccine reminders?
Research shows that text message reminders can increase vaccination rates for both COVID-19 and flu. These reminders are safe, as they are simple messages sent to phones, posing no physical risks. Studies confirm that people generally experience no issues receiving these reminders. Text message reminders offer an easy way to remember vaccine appointments and have been used safely in many places without negative effects.12345
Why are researchers excited about this trial?
Researchers are excited about using text message reminders for pediatric COVID-19 and flu vaccines because they offer a simple, tech-savvy way to boost vaccination rates. Unlike traditional methods that rely on in-person reminders from healthcare providers, text messages can reach parents quickly and directly, fitting seamlessly into their daily routines. This method harnesses the widespread use of mobile phones, potentially increasing accessibility and adherence to vaccine schedules. By testing reminders for both COVID-19 and flu vaccines, as well as each one individually, researchers aim to find the most effective strategy to improve vaccination uptake among children.
What evidence suggests that this trial's text message reminders could be effective for increasing pediatric COVID-19 and flu vaccination rates?
Research has shown that text message reminders can increase vaccination rates for children and teens. In this trial, participants may receive text message reminders for both influenza and COVID-19 vaccinations, or for just one of these vaccines. Studies have found that when parents receive text reminders, more children get their COVID-19 vaccines. Similarly, sending reminders close to the appointment time boosts flu vaccination numbers. Messages mentioning both COVID-19 and flu vaccines can also increase confidence in getting vaccinated. Overall, using text messages effectively reminds people about vaccines and helps ensure more children receive their shots on time.14678
Who Is on the Research Team?
Melissa Stockwell, MD MPH
Principal Investigator
Columbia University
Alex Fiks, MD
Principal Investigator
Children's Hospital of Philadelphia
Are You a Good Fit for This Trial?
This trial is for parents or guardians of children eligible to receive COVID-19 and influenza vaccines. It's focused on those who are part of the AAP PROS network practices, aiming to see if text reminders can improve vaccination rates.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Parents of eligible children receive text message reminders for COVID-19 and/or influenza vaccines
Follow-up
Participants are monitored for vaccine receipt and timeliness
What Are the Treatments Tested in This Trial?
Interventions
- Text Message Reminders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
University of Pennsylvania
Collaborator
American Academy of Pediatrics
Collaborator
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator
Children's Hospital of Philadelphia
Collaborator